Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

744.1000 19.25 (2.66%)

NSE Jul 01, 2025 14:14 PM

New 52W High today

Volume: 3.8M

Laurus Labs Ltd.

22 Oct 2022

744.10

2.66%

Laurus Labs (HOLD): CDMO scale-up masks otherwise dismal Q2; cut to HOLD

Hold: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q2 revenue grew 31% YoY (+2% QoQ) led by synthesis division and other APIs; FDF revenue at record-low of Rs 1.5bn

Number of FII/FPI investors increased from 237 to 259 in Mar 2025 qtr.